The Institut de Recherche pour le Développement, Délégation Régionale Occitanie (IRD-Montpellier), and NeoVentures Biotechnology Europe (NVBE) are proud to announce a strategic partnership to co-develop the NVBE Aptamarker platform for single-cell proteomics.
The Institut de Recherche pour le Développement (IRD), the French National Research Institute for Sustainable Development, is a globally recognized multidisciplinary organization that collaborates with developing countries, particularly in intertropical regions and the Mediterranean. Dr. Arthur Talman, an internationally renowned researcher, is a pioneer in applying transcriptomics to infectious disease agents.
The first project with IRD-Montpellier will utilize the Aptamarker platform for single-cell proteomics to investigate mechanisms involved in Plasmodium falciparum sexual reproduction and malaria transmission. The Aptamarker platform offers a groundbreaking high-plex proteomics approach, enabling unprecedented depth of coverage across diverse species samples.
To keep up-to-date with NeoVentures, check out our LinkedIn profile or our events page here.